AbbVie expects acquisition to cut 2027 adj EPS by about 46c
AbbVie expects the acquisition to negatively impact 2027 adjusted EPS by about 46c, with accretion beginning in 2032.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.